Discovery of 3H-imidazo[4,5-b]pyridines as potent c-Met kinase inhibitors: design, synthesis, and biological evaluation.

about

Discovery of 3H-imidazo[4,5-b]pyridines as potent c-Met kinase inhibitors: design, synthesis, and biological evaluation.

Item

http://www.wikidata.org/entity/Q39348879

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Discovery of 3H-imidazo[4,5-b] ...... is, and biological evaluation.

@en

Discovery of 3H-imidazo[4,5-b] ...... is, and biological evaluation.

@nl

type

Item

label

Discovery of 3H-imidazo[4,5-b] ...... is, and biological evaluation.

@en

Discovery of 3H-imidazo[4,5-b] ...... is, and biological evaluation.

@nl

prefLabel

Discovery of 3H-imidazo[4,5-b] ...... is, and biological evaluation.

@en

Discovery of 3H-imidazo[4,5-b] ...... is, and biological evaluation.

@nl

P1476

Discovery of 3H-imidazo[4,5-b] ...... is, and biological evaluation.

@en

P2093

Bing Xiong

http://www.w3.org/2001/XMLSchema#string

Danqi Chen

http://www.w3.org/2001/XMLSchema#string

Jing Ai

http://www.w3.org/2001/XMLSchema#string

Jingkang Shen

http://www.w3.org/2001/XMLSchema#string

Meiyu Geng

http://www.w3.org/2001/XMLSchema#string

Yi Chen

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

Yuchi Ma

http://www.w3.org/2001/XMLSchema#string

P2860

CAS/Crk coupling serves as a "molecular switch" for induction of cell migration.

Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase

Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors

Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities

Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase

Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2

Pyrrolo[1,2-f]triazines as JAK2 inhibitors: achieving potency and selectivity for JAK2 over JAK3

Met, metastasis, motility and more

Developing c-MET pathway inhibitors for cancer therapy: progress and challenges.

Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

P304

1057-1070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201200120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22581753

http://www.w3.org/2001/XMLSchema#string